Erin Amerson is a Dermatology physician affiliated with San Francisco General Hospital. OpenAlex indexes 80 publications with 1,540 citations (h-index 17).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1701 Divisadero St
3rd Floor
San Francisco, CA 941153011
Telephone
415-353-7800Registry record last updated 29 Feb 2012.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
27.3%Corticosteroid11.6%Triamcinolone Acetonide85%Fluocinolone Acetonide15%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist11.1%Dupixent Syringe67%Dupixent Pen33%Part D<11 patients+ 4 more classes in this area
Cancer & immunology
20.9%Folate Analog Metabolic Inhibitor4.4%Methotrexate100%Part D≥13 patientsTNF inhibitor4.4%Humira Pen57%Humira(Cf) Pen43%Part D<11 patients+ 7 more classes in this area
Anti-infectives
20.3%Azole Antifungal13%Ketoconazole100%Part D≥90 patientsLincosamide Antibacterial2.5%Clindamycin Phosphate56%Clindamycin Hcl44%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Skin cancer risk across racial/ethnic groups among solid organ transplant recipients in the United States, 2000-2022
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Geoffrey Manley, MD, PhD
San Francisco General Hospital
Melvin Cheitlin, MD
San Francisco General Hospital
John Yue, MD
San Francisco General Hospital
Bryan Greenhouse, MD
San Francisco General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”